List of Excipients in Branded Drug TOPCARE ALLERGY

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	BENZALKONIUM CHLORIDE
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	CARBOXYMETHYLCELLULOSE SODIUM
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	CELLULOSE, MICROCRYSTALLINE
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	CITRIC ACID MONOHYDRATE
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	GLYCERIN
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	POLYSORBATE 80
Praxis LLC	TOPCARE ALLERGY	mometasone furoate monohydrate	59368-316	SODIUM CITRATE

Generic Drugs Containing TOPCARE ALLERGY

Company	Ingredient	NDC	Excipient
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	CROSCARMELLOSE SODIUM
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	HYPROMELLOSE
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	LACTOSE MONOHYDRATE
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	MAGNESIUM STEARATE
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	POVIDONE
Topco Associates LLC	loratadine, pseudoephedrine sulfate	36800-611	TITANIUM DIOXIDE

What are the Most Frequently-Used Excipients in TOPCARE ALLERGY?

# Of NDCs	Excipient

Excipient Strategy and Commercial Opportunities for TOPCARE ALLERGY

Last updated: February 26, 2026

What are the key excipient considerations for TOPCARE ALLERGY?

TOPCARE ALLERGY is a multi-component antihistamine formulation designed to treat allergy symptoms. The excipient selection impacts the drug's stability, bioavailability, patient compliance, and manufacturing cost. Critical excipients include fillers, binders, disintegrants, lubricants, and stabilizers.

Typical Excipients in Allergy Medications

• Filler/Diluent: Microcrystalline cellulose, lactose monohydrate, or microcrystalline cellulose are primary options. These maintain dosage form integrity.
• Disintegrants: Croscarmellose sodium or sodium starch glycolate facilitate tablet breakup.
• Binders: Hydroxypropyl methylcellulose (HPMC) ensures tablet cohesion.
• Lubricants: Magnesium stearate prevents sticking during manufacturing.
• Colorants/Flavorings: Used for patient acceptance, particularly in chewables or dispersible forms.

Excipient Selection Criteria

• Compatibility with active pharmaceutical ingredients (API).
• Stability over shelf life.
• Non-toxicity, allergy potential, and regulatory approval.
• Cost and availability.

How does excipient strategy influence manufacturing and marketability?

Choosing excipients with high supply stability and established regulatory pathways reduces risk. For instance, lactose-based excipients are widely accepted but pose challenges for lactose-intolerant populations. Alternatives like microcrystalline cellulose expand suitability. Excipient quality impacts bioavailability; optimized disintegrants improve onset of action, giving a competitive edge.

What commercial opportunities exist with excipient innovation?

Differentiation via Novel Excipients

Developing formulations with advanced excipients that enhance drug stability or release profiles can achieve patent protection. For example, matrix-embedded disintegrants can provide controlled release, extending patent life and market exclusivity.

Market Expansion through Specialty Formulations

• Lactose-Free Options: Address lactose intolerance in sensitive populations.
• Taste-Masked or Dispersible Tablets: Improve pediatric and geriatric adherence.
• Orally Disintegrating Tablets (ODTs): Popular in allergy medications for ease of swallowing.

Strategic Partnerships and Supply Chain

Establishing reliable supply chains for specialized excipients (e.g., starch derivatives, cellulose derivatives) can favor market entry. Collaborations with excipient manufacturers enable co-development and differentiation.

Regulatory and Patent Strategies

Excipients with GRAS (Generally Recognized As Safe) status ease regulatory approval and reduce time-to-market. Patent protection on unique excipient-combinations or delivery systems creates barriers to competitors.

How does regional regulatory variation affect excipient strategy?

Regulatory agencies like the FDA (U.S.), EMA (Europe), and MHRA (UK) have differing approvals and restrictions for excipients. For example, phenylalanine in aspartame-based flavorings is regulated differently, influencing formulation choices. Tailoring excipient strategies regionally can optimize market access.

Summary of Key Challenges and Opportunities

Challenge	Opportunity
Allergic reactions to certain excipients	Use of hypoallergenic excipients
Supply chain disruptions	Development of secondary excipient sources
Regulatory hurdles	Early engagement with authorities

How should the excipient strategy be aligned with clinical and commercial goals?

An optimal approach stresses patient experience, e.g., via taste-masking or dispersible forms. It also emphasizes cost-efficiency and regulatory compliance for broader market access. Innovations in excipients should be protected via patents to sustain competitive advantages.

---

Key Takeaways

• Excipient choice influences formulation stability, bioavailability, and patient compliance.
• Advanced excipients can create formulations with extended patent life and differentiation.
• Regional regulatory differences require tailored excipient strategies.
• Specialty formulations, such as lactose-free or dispersible tablets, expand market reach.
• Supply chain stability for excipients mitigates manufacturing risks.

---

FAQs

Q1: Can excipient innovation protect TOPCARE ALLERGY from generic competition?
Yes, patenting novel excipient combinations or delivery systems can extend exclusivity.

Q2: Are there regulatory concerns with using novel excipients?
Yes, new excipients require safety data and regulatory approval, which can delay market entry.

Q3: How does patient preference influence excipient choices?
Preferences for taste, swallowability, and allergen avoidance impact excipient selection, affecting adherence.

Q4: What role do excipients play in shelf-life extension?
Certain stabilizers and antioxidants protect API integrity, prolonging shelf life.

Q5: How can supply chain stability be improved for excipients?
Diversifying suppliers and developing in-house manufacturing capabilities reduce dependency and risk.

---

References

1. Madan, P., & Jain, S. (2020). Pharmaceutical excipients: An overview. Journal of Pharmaceutical Innovation, 15(3), 245-255.
2. U.S. Food and Drug Administration. (2019). Guidance for Industry: Excipients in Drug Products. https://www.fda.gov
3. European Medicines Agency. (2018). Reflection paper on pharmaceutical excipients. EMA/CHMP/408761/2018.